EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Acetate modulates host physiology and bacterial energetics to improve antibiotic efficacy during obesity-associated infection

Arsalan Hussain iD, Prateek Bhardwaj, Ashish Kumar Ray, Aakash Singh, Abhiroop Sett, Ranjana Pathania iD

mBio · 11.11.2026 · 17 (11)

DOI: 10.1128/mbio.01630-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, erschienen am 11.11.2026. Verfasst von Arsalan Hussain und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee, India. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Obesity, Acetates, Acinetobacter baumannii. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Human Resource and Development, India, Council of Scientific and Industrial Research, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibiotic efficacy is conventionally attributed to the susceptibility of the infecting pathogen. However, obese patients experience disproportionately poor infection outcomes despite receiving antibiotics to which pathogens remain genetically susceptible. These observations suggest that host-associated factors can influence treatment outcomes independently of the bacterial genotype, although the underlying mechanisms remain poorly understood. Using a mechanistic comparison of diet-induced obese and healthy mice infected with Acinetobacter baumannii , we demonstrate that the effect of antibiotics is not solely a property of the pathogen but can be governed by a gut microbiota-derived metabolite acting on both host immunity and bacterial physiology. We identify obesity-associated acetate depletion as a key driver of antibiotic treatment failure, linking gut microbial metabolism to antibiotic activity during infection. We observed that this depletion impaired innate immune activation, reducing cytokine responses and neutrophil-mediated bacterial clearance. Under these conditions, A. baumannii displayed enhanced tolerance to bactericidal antibiotics, particularly tobramycin. Given these findings, we investigated whether acetate could be leveraged therapeutically to restore antibiotic efficacy. We observed that oral acetate supplementation remodeled the dysbiotic microbiome, whereas systemic acetate restored innate immune competence and neutrophil-mediated bacterial clearance. Most importantly, acetate reversed antibiotic tolerance and restored aminoglycoside killing by directly sensitizing host-induced tolerant bacterial populations. Mechanistically, acetate directly reprogrammed bacterial physiology to enhance aminoglycoside-mediated killing. Combined acetate-tobramycin treatment resulted in eradication of tolerant populations and markedly improved bacterial clearance in vivo . Our findings establish a mechanistic link between host metabolic state and antibiotic efficacy and identify acetate as a therapeutic intervention for obesity-associated gram-negative infections. IMPORTANCE Antibiotic treatment failure in obese patients remains poorly understood and therapeutically unaddressed. This study reveals that host metabolic state can control antibiotic response through a gut microbiota-derived metabolite that acts on both host defense and bacterial physiology. We identify obesity-driven depletion of microbiota-derived acetate as a previously unrecognized determinant of antibiotic failure, operating independently of bacterial resistance. By simultaneously restoring gut microbial balance, rescuing impaired innate immunity, and directly sensitizing pathogens to aminoglycoside killing through bacterial membrane alteration, acetate supplementation addresses the host-pathogen-microbiome axis through a single intervention. Given its established clinical safety, acetate represents a compelling combination therapy alongside aminoglycosides in obesity-associated gram-negative infections in a population for which host-directed treatment strategies are currently limited.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsObesityAcetatesAcinetobacter baumanniiAcinetobacter InfectionsAnimalsMiceImmunity, InnateGastrointestinal MicrobiomeMice, Inbred C57BLNeutrophilsMaleTobramycin

Stichwörter der Autor:innen

aminoglycosidesgram-negative infectionshost-directed therapyshort-chain fatty acidstreatment failure

Substanzen

Anti-Bacterial AgentsAcetatesTobramycin

Autor:innen und Institutionen

  • Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee, India.

ORCID-Profile: Arsalan Hussain, Ranjana Pathania

Förderung

  • Ministry of Human Resource and Development, India
  • Council of Scientific and Industrial Research, India

Zitieren

APA

Hussain, A., Bhardwaj, P., Ray, A. K., Singh, A., Sett, A., & Pathania, R. (2026). Acetate modulates host physiology and bacterial energetics to improve antibiotic efficacy during obesity-associated infection. mBio, 17(11). https://doi.org/10.1128/mbio.01630-26

Vancouver

Hussain A, Bhardwaj P, Ray AK, Singh A, Sett A, Pathania R. Acetate modulates host physiology and bacterial energetics to improve antibiotic efficacy during obesity-associated infection. mBio. 2026;17(11). doi:10.1128/mbio.01630-26

BibTeX
@article{Hussain2026,
  author = {Hussain, Arsalan and Bhardwaj, Prateek and Ray, Ashish Kumar and Singh, Aakash and Sett, Abhiroop and Pathania, Ranjana},
  title = {Acetate modulates host physiology and bacterial energetics to improve antibiotic efficacy during obesity-associated infection},
  journal = {mBio},
  year = {2026},
  volume = {17},
  number = {11},
  doi = {10.1128/mbio.01630-26}
}
Kostenlos starten →